Solace Herbals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 22 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 2.00 M
- Revenue Growth -66.40%
- Profit Growth -3996.12%
- Ebitda -93.55%
- Net Worth -51.09%
- Total Assets -6.47%
About Solace Herbals
Solace Herbals Private Limited (SHPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 September 2002 and has a history of 22 years and five months. Its registered office is in Cooch Behar, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.00 M.
Dulal Debnath and Pratima Debnath serve as directors at the Company.
Company Details
- Location
Cooch Behar, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909WB2002PTC095091
- Company No.
095091
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 2002
- Date of AGM
16 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Solace Herbals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dulal Debnath  | Director | 02-Sep-2002 | Current |
| Pratima Debnath | Director | 02-Sep-2002 | Current |
Financial Performance of Solace Herbals.
Solace Herbals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 66.4% decrease. The company also saw a substantial fall in profitability, with a 3996.12% decrease in profit. The company's net worth observed a substantial decline by a decrease of 51.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Solace Herbals?
In 2019, Solace Herbals had a promoter holding of 81.00% and a public holding of 19.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dulal Polyclinic Private LimitedDulal Debnath and Pratima Debnath are mutual person
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jan 2004 | Bank Of Baroda | ₹2.00 M | Open |
How Many Employees Work at Solace Herbals?
Unlock and access historical data on people associated with Solace Herbals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Solace Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solace Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.